浦辺 雅之 うらべ まさゆき 先生

来歴等

略歴

2008年 東京大学医学部医学科 卒業
2010年 茅ヶ崎市立病院 一般・消化器外科 医員
2013年 東京大学医学部附属病院 胃食道外科 助教
2018年 東京大学大学院医学系研究科 博士課程修了
2018年 虎の門病院 消化器外科 医員
2021年 東京大学医学部附属病院 胃食道外科 助教
2024年 大森赤十字病院 外科（上部消化管） 部長

論文

• 1. Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses. Gastric Cancer 2023;26(1):95-107

  Urabe M, Matsusaka K, Ushiku T, Fukuyo M, Bahityar R, Yamashita H, Seto Y, Fukayama M, Kaneda A.

• 2. Duodenal diversion surgery in management of intractable tracheobroncho-gastric fistula after esophagectomy. Gen Thorac Cardiovasc Surg Case 2023:2(1):58

  Urabe M, Yagi K, Yoshimura S, Ri M, Yajima S, Okumura Y, Seto Y.

• 3. Laparoscopic and endoscopic cooperative surgery as palliative treatment for elderly patients with gastric cancer. Nagoya J Med Sci 2023;85(4):807-13

  Urabe M, Okumura Y, Okamoto A, Yagi K, Tsuji Y, Yamashita H, Fujishiro M, Seto Y.

• 4. Esophageal cancer surgery in dialyzed patients: a single institution case series. Ann Thorac Cardiovasc Surg 2022;28(5):366-70

  Urabe M, Ueno M, Yago A, Shimoyama H, Ohkura Y, Haruta S, Udagawa H.

• 5. Implications of liver-directed therapy for postoperative hepatic metastasis from esophageal cancer. J Chest Surg 2022;55(5):397-404

  Urabe M, Yagi K, Shiomi S, Toriumi T, Okumura Y, Seto Y.

• 6. Coexistence of aberrant left hepatic artery and duplicated left gastric artery: a potential surgical pitfall. ANZ J Surg 2022;92(6):1551-2

  Urabe M, Haruta S, Ueno M.

• 7. Factors affecting blood loss during thoracoscopic esophagectomy for esophageal carcinoma. J Chest Surg 2021;54(6):466-72

  Urabe M, Ohkura Y, Haruta S, Ueno M, Udagawa H.

• 8. Spontaneous mesenteric haematoma: a diagnostic dilemma. ANZ J Surg 2021;91(9):1941-3

  Urabe M, Kojima K, Kinowaki K, Haruta S, Ueno M.

• 9. Management and outcomes of resectable gastric conduit cancer: a retrospective comparative study of 51 cases. Langenbecks Arch Surg 2021;406(5):1433-41

  Urabe M, Haruta S, Tanaka M, Yago A, Ohkura Y, Tanaka T, Hoteya S, Ueno M, Udagawa H.

• 10. Comparative analysis of the prognostic utility of preoperative nutritional parameters in patients with resectable esophageal carcinoma. Gen Thorac Cardiovasc Surg 2021;69(2):326-35

  Urabe M, Ueno M, Ogawa Y, Yago A, Shimoyama H, Honda A, Ohkura Y, Haruta S, Udagawa H.

• 11. Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: experiences related to esophageal cancer surgery. Head Neck 2020;42(10):3098-9

  Urabe M, Ueno M, Udagawa H.

• 12. Factors impacting survival outcomes after curative resection for primary duodenal adenocarcinoma. Surg Gastroenterol Oncol 2020;25(3):132-9

  Urabe M, Shindoh J, Kobayashi Y, Okubo S, Haruta S, Ueno M, Hashimoto M.

• 13. Percutaneous endoscopic gastrostomy with jejunal extension for a post-esophagectomy gastric conduit. Clin J Gastroenterol 2020;13(4):501-5

  Urabe M, Koga S, Ohkura Y, Ueno M, Udagawa H.

• 14. Diaphragmatic herniation following total gastrectomy: review of the long-term experience of a tertiary institution. Langenbecks Arch Surg 2019;404(8):993-8

  Urabe M, Haruta S, Ohkura Y, Yago A, Koga S, Tanaka T, Ueno M, Udagawa H.

• 15. Prognostic significance of neutrophil-to-lymphocyte ratio in solid tumors: a note on methodological concerns. Biomark Med 2019;13(17):1429-32

  Urabe M, Yamashita H, Seto Y.

• 16. Clinicopathological presentations and surgical outcomes of esophageal melanoma. Asian Cardiovasc Thorac Ann 2019;27(7):548-53

  Urabe M, Haruta S, Ohkura Y, Inoshita N, Yago A, Koga S, Tanaka T, Ueno M, Udagawa H.

• 17. Giant Brunner’s gland adenoma of the duodenum manifested by melena. ANZ J Surg 2019;89(9):1166-7

  Urabe M, Yamashita H, Nishida M, Seto Y.

• 18. Gastric cancer with solitary liver metastasis accompanied by cyst formation. ANZ J Surg 2019;89(6):784-5

  Urabe M, Yamashita H, Akamatsu N, Seto Y.

• 19. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: a comparative analysis according to Siewert classification in a Japanese cohort. Cancer Med 2018;7(10):5145-54

  Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M.

• 20. Non-linear association between long-term outcome and preoperative neutrophil-to-lymphocyte ratio in patients undergoing curative resection for gastric cancer: a retrospective analysis of 1335 cases in a tetrachotomous manner. Jpn J Clin Oncol 2018;48(4):343-9

  Urabe M, Yamashita H, Uemura Y, Tanabe A, Yagi K, Aikou S, Seto Y.

• 21. Comparison of prognostic abilities among preoperative laboratory data indices in patients with resectable gastric and esophagogastric junction adenocarcinoma. World J Surg 2018;42(1):185-94

  Urabe M, Yamashita H, Watanabe T, Seto Y.

• 22. Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in patients with resectable gastroesophageal junction and gastric cancer. Ann Surg 2017;266(6):e76-7

  Urabe M, Yamashita H, Seto Y.

• 23. Pathologic response of HER2-positive gastric cancer to trastuzumab-based chemotherapy. Am J Surg Pathol 2016;40(10):1326-33

  Urabe M, Ushiku T, Seto Y, Fukayama M.

• 24. Solitary fibrous tumor of the greater omentum, mimicking gastrointestinal stromal tumor of the small intestine: a case report. Int Surg 2015;100(5):836-40

  Urabe M, Yamagata Y, Aikou S, Mori K, Yamashita H, Nomura S, Shibahara J, Fukayama M, Seto Y.

• 25. Primary adenocarcinoma in the middle thoracic esophagus, which revealed scirrhous-like growth. Esophagus 2014;12(4):365-9

  Urabe M, Mori K, Nishida M, Yagi K, Yamagata Y, Aikou S, Yamashita H, Nomura S, Shinozaki-Ushiku A, Fukayama M, Seto Y.

受賞

• International Academy of Pathology Japanese Division Young Researchers' Award 2017